Bulletin from Elekta's Annual General Meeting 2011

Bulletin from Elekta's Annual General Meeting 2011

A total of 433 shareholders who were entitled to vote, representing
59,45 per cent of the total votes, participated in the annual general
meeting of Elekta AB (publ).

  · Per-share dividend to shareholders of SEK 4.00 (3.00)
  · Akbar Seddigh, Hans Barella, Luciano Cattani, Vera Kallmeyer,
Laurent Leksell, Jan Secher and Birgitta Stymne Göransson were reelected
to the board
  · Siaou-Sze Lien and Wolfgang Reim were elected new members of the
board

Elekta CEO Tomas Puusepp began his presentation by stressing the
importance of an innovative approach for companies that want to remain
in the forefront of development. Ever since its earliest days, Elekta
has never lost sight of that attitude.

Mr. Puusepp commented on the company's performance during fiscal year
2010/11 and the first quarter of 2011/12, as well as the forecast for
the entire year.

He also described Elekta's strategy and focus on growth.

"We expect the pace of our geographical expansion to accelerate over the
next few years, providing more people around the world with access to
cancer care. Elekta is already a leader in most growth markets, which
now account for approximately one-third of group sales."

Mr. Puusepp offered several examples of growth drivers in the area of
cancer care:

-       Due to rising prosperity, people are living longer and
developing cancer and other age-related diseases.

-       Access to care is unevenly distributed around the world, which
is creating growing demand in developing countries.

-       Hospitals and patients are asking for non-invasive treatment
options more than ever before.

-       Healthcare systems are becoming more advanced and dependent on
IT applications.

In closing, Mr. Puusepp thanked Elekta's employees for their
extraordinary efforts during the year.

Appropriation of profits

Elekta's dividend policy is to distribute at least 30% of net profit in
the form of dividends, share buybacks or similar initiatives.

In accordance with the board's proposal, the meeting voted that a
per-share dividend of SEK 4.00 would be distributed to shareholders and
that the rest of the unappropriated earnings of SEK 1,531,223,172 would
be carried forward to new account. The record day for the dividend was
set for September 16, 2011. Payment from Euroclear Sweden AB is expected
on September 21, 2011.

Adoption of the income statement and balance sheet

The meeting adopted the income statement and balance sheet for the
parent company, as well as the consolidated income statement and
consolidated balance sheet, as of April 30, 2011. The members of the
board and CEO were discharged from liability for fiscal year 2010/11.

Election of the board and remuneration

In accordance with the proposal of the nomination committee, the meeting
reelected Akbar Seddigh, Hans Barella, Luciano Cattani, Vera Kallmeyer,
Laurent Leksell, Jan Secher and Birgitta Stymne Göransson to the board,
while electing Siaou-Sze Lien and Wolfgang Reim as new members of the
board. Mr. Seddigh was reelected as chairman of the board.

In accordance with the proposal of the nomination committee, the meeting
approved that remuneration of SEK 3,465,000 (2,890,000) is to be paid to
the board, including SEK 725,000 (625,000) to the chairman of the board,
SEK 330,000 (310,000) to each external member of the board, SEK 70,000
(unchanged) to the chairman and SEK 35,000 (unchanged) to other members
of the remuneration committee, SEK 150,000 (120,000) to the chairman and
SEK 70,000 (60,000) to other members of the audit committee. No board
member who is employed by the company is to receive remuneration or
compensation for committee work.

Guidelines for remuneration to executive management

Mr. Seddigh explained Elekta's remuneration structure for executive
management. In accordance with the board's proposal, the meeting
approved guidelines for remuneration and other terms of employment for
executive management. The guidelines apply to employment contracts that
are signed after the meeting's approval, as well as cases in which
changes are made to existing contracts after that date.

Approval of Performance Share Program 2011

In accordance with the board's proposal, the meeting approved adoption
of Performance Share Program 2011. The program covers approximately 120
key personnel, who will have the chance to receive free allotment of
Class B Elekta shares. Assuming that a maximum number of shares are
allotted under Performance Share Program 2011 at a price of SEK 250, the
costs, including social security contributions and financing of
repurchased shares, will be an estimated SEK 66,500,000.

Acquisition and transfer of own shares

The meeting authorized the board to make one or more acquisitions of own
shares until the next annual general meeting such that the company does
not hold more than 10 percent of all shares. The meeting also authorized
the board to make one or more transfers of own shares until the next
annual general meeting to finance takeovers or other types of strategic
investments.

In view of Performance Share Program 2011, the meeting approved transfer
of up to 266,000 own shares and authorized the board to make one or more
transfers on the Nasdaq OMX Stockholm Exchange until the next annual
general meeting for a total of up to 36,700 shares in order to cover
certain fees, primarily social security contributions.

In view of Performance Share Programs 2009 and 2010, the meeting
authorized the board to make one or more transfers on the Nasdaq OMX
Stockholm Exchange until the next annual general meeting, for a total of
up to 47,250 shares in order to cover certain fees, primarily social
security contributions.

Amendment to the articles of association

In accordance with the board's proposal, the meeting approved an
amendment to section 7 of the articles of association to the effect that
the auditor will continue to have a four-year term.

Nomination Committee

The meeting approved the proposed procedure for appointing members of
the nomination committee for the 2012 annual general meeting, as well as
the committee's assignment.

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
+46 8 587 254 37, stina.thorman@elekta.com (stina.thorman@elekta.com)

About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy and radiosurgery, as well as workflow
enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients
receive diagnosis, treatment or follow-up with the help of a solution
from the Elekta Group.

Elekta employs around 2,800 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is listed
on the Nordic Exchange under the ticker Elekta. Website:
www.elekta.com (http://www.elekta.com/)